iRhythm Holdings, Inc. IRTC
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
5/9
Piotroski F — financial health
0.78
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $747.1M | -$44.6M | $527.2M | $34.5M | $152.7M |
| 2024 | $591.8M | -$113.3M | $407.5M | -$30.6M | $90.9M |
| 2023 | $492.7M | -$123.4M | $331.8M | -$90.5M | $210.1M |
| 2022 | $410.9M | -$116.2M | $281.6M | -$52.8M | $239.8M |
| 2021 | $322.8M | -$101.4M | $213.6M | -$65.8M | $279.5M |
| 2020 | $265.2M | -$43.8M | $194.9M | -$27.3M | $341.6M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Shrishrimal Sumi | EVP, Chief Risk Officer | 2026-06-02 | Sell | 1,716 | $108.19 |
| Rosenbaum Marc Wade | Chief Accounting Officer | 2026-06-02 | Sell | 729 | $108.19 |
| Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH | 2026-05-29 | Grant | 137 | $96.81 |
| Patterson Chad | CHIEF COMM & PRODUCT OFFICER | 2026-05-29 | Grant | 177 | $96.81 |
| Freeman Sean Clinton | EVP, Strategy & Corp Devt | 2026-05-29 | Grant | 273 | $96.81 |
| Blackford Quentin S. | President and CEO | 2026-05-29 | Grant | 178 | $96.81 |
| Shrishrimal Sumi | EVP, Chief Risk Officer | 2026-05-29 | Grant | 133 | $96.81 |
| Rosenbaum Marc Wade | Chief Accounting Officer | 2026-05-29 | Grant | 178 | $96.81 |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 0.78 (distress)
- Working capital / assets 0.54
- Retained earnings / assets -0.788
- EBIT / assets -0.056
- Equity / liabilities 0.176
Source: SEC EDGAR filings · CIK 0001388658 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.